KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 143 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 1.33 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $122,955,000 | -10.9% | 6,491,812 | -9.6% | 7.37% | -28.3% |
| Q1 2020 | $137,941,000 | +17.4% | 7,180,700 | +17.2% | 10.27% | +43.3% |
| Q4 2019 | $117,463,000 | +109.2% | 6,127,434 | +5.0% | 7.17% | +29.0% |
| Q3 2019 | $56,156,000 | +61.5% | 5,837,434 | +0.6% | 5.56% | +125.9% |
| Q2 2019 | $34,761,000 | +15.4% | 5,803,227 | +12.5% | 2.46% | +29.3% |
| Q1 2019 | $30,128,000 | -33.2% | 5,158,884 | +7.3% | 1.90% | -42.6% |
| Q4 2018 | $45,070,000 | -45.2% | 4,810,078 | -0.4% | 3.32% | -25.1% |
| Q3 2018 | $82,205,000 | +1.5% | 4,827,078 | +1.3% | 4.43% | -15.3% |
| Q2 2018 | $80,993,000 | – | 4,767,078 | – | 5.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Delphi Management Partners VIII, L.L.C. | 2,263,006 | $13,170,000 | 9.51% |
| Palo Alto Investors LP | 5,383,052 | $31,329,000 | 1.89% |
| Birchview Capital, LP | 246,000 | $1,432,000 | 0.97% |
| Rubric Capital Management LP | 3,375,758 | $19,647,000 | 0.55% |
| Lombard Odier Asset Management (Switzerland) SA | 1,517,804 | $8,834,000 | 0.55% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,401,861 | $8,159,000 | 0.30% |
| AlphaCentric Advisors LLC | 136,000 | $792,000 | 0.20% |
| Bridgefront Capital, LLC | 20,946 | $122,000 | 0.13% |
| Hennion & Walsh Asset Management, Inc. | 407,474 | $2,371,000 | 0.12% |
| Virtus ETF Advisers LLC | 44,364 | $258,000 | 0.11% |